Back to search

United States· US:0363-0733_e89d2575-c3c1-4633-866c-cecba7d52370

Mucus Relief DM Extended Release Caplets

A medicinal product containing guaifenesin; dextromethorphan hydrobromide, registered in United States by Walgreens.

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedMucus Relief DM Extended Release Capl…ATC—REGISTER NO.US:0363-0733_e89d2575…PACKS LISTED4CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
GUAIFENESIN; DEXTROMETHORPHAN HYDROBROMIDE
Manufacturer
Walgreens
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 4

  • ndc11
    0363073320
    20 BLISTER PACK in 1 CARTON (0363-0733-20) / 1 TABLET in 1 BLISTER PACK
  • ndc11
    0363073340
    40 BLISTER PACK in 1 CARTON (0363-0733-40) / 1 TABLET in 1 BLISTER PACK
  • ndc11
    0363-0733-20
  • ndc11
    0363-0733-40

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Guaifenesin; dextromethorphan hydrobromide in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All guaifenesin; dextromethorphan hydrobromide products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • Spain · Broncomedical Con Guaifenesina, Cinfatós Expectorante
  • Italy · Bronchenolo Sedativo E Fluidificante, Bronchenolo Sedativo E Fluidificante Gusto Menta

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fc969cbb-4331-4aeb-bd43-aee619182702
GET /v1/drugs/fc969cbb-4331-4aeb-bd43-aee619182702?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "600; 30",
  "substance": "GUAIFENESIN; DEXTROMETHORPHAN HYDROBROMIDE",
  "productndc": "0363-0733",
  "dosage_form": "TABLET",
  "dea_schedule": null,
  "strength_unit": "mg/1; mg/1",
  "application_number": "ANDA209692",
  "marketing_category": "ANDA"
}

See everything about guaifenesin; dextromethorphan hydrobromide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.